There is broad consensus that the overall body of evidence shows lowering LDL (low-density lipoprotein) cholesterol provides both statistically significant and clinically meaningful benefits in ...

Add Yahoo as a preferred source to see more of our stories on Google. Dr. Charles Hennekens, a medical school professor and heart disease researcher at Florida Atlantic University in Boca Raton, Fla., ...

LONDON, England—Aggressive cholesterol lowering at the time of hospitalization for MI results in better clinical outcomes at 1 year when compared with the current stepwise treatment strategy, ...

High cholesterol is one of the most common and manageable risk factors for heart disease. Millions of adults are prescribed cholesterol-lowering drugs to reduce low-density lipoprotein (LDL) ...

Sanofi and Regeneron’s PCSK9 inhibitor alirocumab—one of a group of antibodies heralded as the next class of cholesterol-lowering agents—has had its day in the Barcelona sun at the European Society of ...

NEW YORK (Reuters Health) - People with heart problems who were started on cholesterol-lowering statins were more likely to develop diabetes if they were prescribed stronger versions of the drugs, a ...

Researchers from FAU's Schmidt College of Medicine urge practicing cardiologists to achieve lower LDL cholesterol levels beginning with the highest doses of the most potent statins, namely ...